Jiri Vachtenheim

8PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRespiratory diseasesSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2026
Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study.

|Apr 17, 2026
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma.

|Feb 18, 2025
Bilateral lung herniation with parenchymal infarction following clamshell thoracotomy for lobar lung transplantation: a case report.

Janis Tavandžis, René Novysedlák, Jiří Pozniak

|Mar 22, 2024
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.

Lenka Kasikova, Jana Rakova, Michal Hensler

|Aug 27, 2021
Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective?

Andrej Ozaniak, Jiri Vachtenheim, Robert Lischke

|Oct 26, 2020
Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report.

Jiri Vachtenheim, Roman Kodet, Ondrej Fischer

Pageof 2

Frequent Collaborators

2 joint publications

Zuzana Strizova

2 joint publications

Marek Kovar

2 joint publications

Francis Jacob

2 joint publications

Jitka Fucikova